Managing demand for laboratory tests: A laboratory toolkit

Journal of Clinical Pathology

Volumn 66, Issue 1, 2013, Pages 62-72

  Fryer, Anthony A ^a   Smellie, W Stuart A ^b  

^a KEELE UNIVERSITY   (United Kingdom)

^b Bishop Aukland General Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COST BENEFIT ANALYSIS; DEMAND MANAGEMENT; EDUCATION; FINANCIAL MANAGEMENT; GENERAL PRACTITIONER; HEALTH CARE PLANNING; HEALTH SERVICE; INFORMATION TECHNOLOGY; LABORATORY DEVICE; LABORATORY TEST; NATIONAL HEALTH SERVICE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROFESSIONAL STANDARD; PUNISHMENT; REVIEW; WORKLOAD;

CLINICAL CHEMISTRY TESTS; DIAGNOSTIC TESTS, ROUTINE; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; PATHOLOGY DEPARTMENT, HOSPITAL; PRACTICE GUIDELINES AS TOPIC; UNNECESSARY PROCEDURES;

EID: 84871919358     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jclinpath-2011-200524     Document Type: Review

References (100)

1. Report of the Second Phase of the Review of NHS Pathology Services in England. Chaired by Lord Carter of Coles. Dec 2008. http://www.dh.gov.uk/en/ Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH-091985 (accessed Aug 2012).
2. Fryer AA, Hanna FW. Managing demand for pathology tests: financial imperative of duty of care? Ann Clin Biochem 2009;46:435-7.
3. Janssens PMW. Managing the demand for laboratory testing: Options and opportunities. Clin Chim Acta 2010;411:1596-602.
4. Alonso-Cerezo MC, Martín JS, García Montes MA, et al. Appropriate utilization of clinical laboratory tests. Clin Chem Lab Med 2009;47:1461-5.
5. National Coalition of Public Pathology. Encouraging Quality Pathology Ordering in Australia's Public Hospitals - Final Report. Feb 2012. http://www.ncopp.org.au/UserFiles/file/ NCOPP%20QUPP%20Project%20Final%20Report%20(web).pdf (accessed Aug 2012).
6. Smellie WSA. Demand management and test request rationalization. Ann Clin Biochem 2012;49:323-36.
7. Jackson BR. Managing laboratory test use: principles and tools. Clin Lab Med 2007;27:733-48. (Pubitemid 47576513)
8. Rao GG, Crook M, Tillyer ML. Pathology tests: is the time for demand management ripe at last? J Clin Pathol 2003;56:243-8. (Pubitemid 36459791)
9. Van Walraven C, Naylor D. Do we know what inappropriate laboratory utilisation is? JAMA 1998;280;550-8.
10. Marosits MJ. Improving financial and patient outcomes: the future of demand management. Healthc Financ Manage 1997;51:43-4. (Pubitemid 28193207)
11. Sharma A, Inder B. Impact of co-located general practitioner (GP) clinics and patient choice on duration of wait in the emergency department. Emerg Med J 2011;28:658-61.
12. Brogan C, Lawrence D, Mayhew L. Clinical-outcome-based demand management in health services. Public Health 2008;122:84-91. (Pubitemid 350246237)
13. Sood R, Sood A, Ghosh AK. Non-evidence-based variables affecting physicians' test-ordering tendencies: a systematic review. Neth J Med 2007;65:167-77. (Pubitemid 47161618)
14. Miyakis S, Karamanof G, Liontos M, et al. Factors contributing to inappropriate ordering of tests in an academic medical department and the effect of an educational feedback strategy. Postgrad Med J 2006;82:823-9. (Pubitemid 46101932)
15. Khromova V, Gray TA. Learning needs in clinical biochemistry for doctors in foundation years. Ann Clin Biochem 2008;45:33-8. (Pubitemid 351724611)
16. Thomas RE, Croal BL, Ramsay C, et al. Effect of enhanced feedback and brief educational reminder messages on laboratory test requesting in primary care: a cluster randomised trial. Lancet 2006;367:1990-6. (Pubitemid 43867700)
17. van Bokhoven MA, Pleunis-van Empel MC, Koch H, et al. Why do patients want to have their blood tested? A qualitative study of patient expectations in general practice. BMC Fam Pract 2006;7:75.
18. Lewandrowski K. Managing utilization of new diagnostic tests. Clin Leadersh Manag Rev 2003;17:318-24.
19. Hampton JR, Harrison MJ, Mitchell JR, et al. Relative contributions of history-taking, physical examination, and laboratory investigation to diagnosis and management of medical outpatients. Br Med J 1975;2:486-9.
20. National Institute for Health and Clinical Excellence. Type 1 diabetes (CG15). http://guidance.nice.org.uk/CG15 (accessed Aug 2012).
21. National Institute for Health and Clinical Excellence. Type 2 diabetes (CG66). http://guidance.nice.org.uk/CG66 (accessed Aug 2012).
22. Smellie WS, Finnigan DI, Wilson D, et al. Methodology for constructing guidance. J Clin Pathol 2005;58:249-53.
23. Smellie WSA, Galloway MJ, Chinn D. Is clinical practice variability the major reason for differences in pathology requesting patterns in general practice? J Clin Pathol 2002;55:312-14. (Pubitemid 34293402)
24. O'Kane MJ, Casey L, Lynch PLM, et al. Clinical outcome indicators, disease prevalence and test request variability in primary care. Ann Clin Biochem 2011;48:155-8.
25. Driskell OJ, Holland D, Hanna FW, et al. Inappropriate requesting of HbA1c is widespread: Assessment of prevalence, impact of national guidance and practice-to-practice variability. Clin Chem 2012;58:906-15.
26. Mindemark M, Wernroth L, Larsson A. Costly regional variations in primary health care test utilization in Sweden. Scand J Clin Lab Invest 2010;70:164-70.
27. Leurquin P, Van Casteren V, De Maeseneer J. Use of blood tests in general practice: a collaborative study in eight European countries. Eurosentinel Study Group. Br J General Practice 1995;45:21-5.
28. NHS National Pathology Benchmarking Service: http://www.ychi.leeds.ac.uk/ benchmarking/Background/Toolstotry/ExampleOutputs/tabid/87/Default.aspx (accessed Aug 2012).
29. McDonnell M; Northern Ireland Regional Audit Group. An audit of tumour marker requests in Northern Ireland. Ann Clin Biochem 2004;41:378-84.
30. Walker PL, Crook M. Tumour marker requesting in primary care and the role of the laboratory. J Clin Pathol 2011;64:443-6.
31. Wu AH, Lewandrowski K, Gronowski AM, et al. Antiquated tests within the clinical pathology laboratory. Am J Manag Care 2010;16:e220-7.
32. Fraser CG. Faecal occult blood tests - eliminate, enhance or update? Ann Clin Biochem 2008;45:117-21. (Pubitemid 351724580)
33. McMahon CG, Lamont JV, Curtin E, et al. Diagnostic accuracy of heart-type fatty acid-binding protein for the early diagnosis of acute myocardial infarction. Am J Emerg Med 2012;30:267-74.
34. MacMillan D, Lewandrowski E, Lewandrowski K. An analysis of reference laboratory (send out) testing: an 8-year experience in a large academic medical center. Clin Leadersh Manag Rev 2004;18:216-19. (Pubitemid 40022625)
35. Crispin PJ, Burgess M, Crispin TM. Transfusion demand control strategies: potential efficacy of hospital and regional interventions. Transfus Apher Sci 2010;43:341-5.
36. Srivastava R, Bartlett WA, Kennedy IM, et al. Reflex and reflective testing: efficiency and effectiveness of adding on laboratory tests. Ann Clin Biochem 2010;47:223-7.
37. Finn AF Jr, Valenstein PN, Burke MD. Alteration of physicians' orders by non physicians. JAMA 1988;259:2549-52.
38. Jones BJ, Twomey PJ. Comparison of reflective and reflex testing for hypomagnesaemia in severe hypokalaemia. J Clin Pathol 2009;62:816-19.
39. Paterson JR, Paterson R. Reflective testing: how useful is the practice of adding on tests by laboratory clinicians? J Clin Pathol 2004;57:273-5. (Pubitemid 38338839)
40. Fraser CG. Reference change values: the way forward in monitoring. Ann Clin Biochem 2009;46:264-5.
41. National Pathology Benchmarking Service. http://www.keele.ac.uk/pharmacy/ general/npbs/ (accessed Aug 2012).
42. van Walraven C, Raymond M. Population-based study of repeat laboratory testing. Clin Chem 2003;49:1997-2005. (Pubitemid 37449471)
43. Salvagno GL, Lippi G, Targher G, et al. Monitoring glycaemic control: is there evidence for appropriate use of routine measurement of glycated haemoglobin? Clin Chem Lab Med 2007;45:1065-7. (Pubitemid 47424860)
44. Guidelines and Audit Implementation Network. Guidelines on the use of the Laboratory. 2008. http://www.gain-ni.org/Publications/Guidelines/Lab-Guide.pdf (accessed Aug 2012).
45. Solomon DH, Hashimoto H, Daltroy L, et al. Techniques to improve physicians ' use of diagnostic tests: a new conceptual framework. JAMA 1998;280:2020-7.
46. Axt-Adam P, van der Wouden JC, van der Does E. Influencing behavior of physicians ordering laboratory tests: a literature study. Med Care 1993;31:784-94.
47. Verstappen WH, van Merode F, Grimshaw J, et al. Comparing cost effects of two quality strategies to improve test ordering in primary care: a randomized trial. Int J Qual Health Care 2004;16:391-8. (Pubitemid 39359427)
48. Wang TJ, Mort EA, Nordberg P, et al. A utilization management intervention to reduce unnecessary testing in the coronary care unit. Arch Intern Med 2002;162:1885-90.
49. Bunting PS, Van Walraven C. Effect of a controlled feedback intervention on laboratory test ordering by community physicians. Clin Chem 2004;50:321-6. (Pubitemid 38156372)
50. Calderon-Margalit R, Mor-Yosef S, Mayer M, et al. An administrative intervention to improve the utilization of laboratory tests within a university hospital. Int J Qual Health Care 2005;17:243-8. (Pubitemid 40873069)
51. Gama R, Nightingale PG, Broughton PM, et al. Modifying the request behaviour of clinicians. J Clin Pathol 1992;45:248- 9.
52. Mindemark M, Larsson A. Long-term effects of an education programme on the optimal use of clinical chemistry testing in primary health care. Scand J Clin Lab Invest 2009;69:481-6.
53. Karas S Jr. Cost containment in emergency medicine. JAMA 1980;243:1356-9.
54. Marton KI, Tul V, Sox HC Jr. Modifying test-ordering behavior in the outpatient medical clinic. A controlled trial of two educational interventions. Arch Intern Med 1985;145:816-21. (Pubitemid 15033240)
55. Wong ET, McCarron MM, Shaw ST Jr. Ordering of laboratory tests in a teaching hospital. Can it be improved? JAMA 1983;249:3076-80.
56. Isouard G. A quality management intervention to improve clinical laboratory use in acute myocardial infarction. Med J Aust 1999;170:11-14. (Pubitemid 29021054)
57. Schroeder SA, Myers LP, McPhee SJ, et al. The failure of physician education as a cost containment strategy. Report of a prospective controlled trial at a university hospital. JAMA 1984;252:225-30. (Pubitemid 14081789)
58. Hutton HD, Drummond HS, Fryer AA. The rise and fall of C-reactive protein: managing demand within clinical biochemistry. Ann Clin Biochem 2009;46:155-8.
59. Prat G, Lefèvre M, Nowak E, et al. Impact of clinical guidelines to improve appropriateness of laboratory tests and chest radiographs. Intensive Care Med 2009;35:1047-53.
60. Jacobsz LA, Zemlin AE, Roos MJ, et al. Chemistry and haematology sample rejection and clinical impact in a tertiary laboratory in Cape Town. Clin Chem Lab Med 2011;49:2047-50.
61. Gama R, Hartland AJ, Holland MR. Changing clinicians' laboratory test requesting behaviour: can the poacher turn gamekeeper? Clin Lab 2001;47:57-66. (Pubitemid 32120084)
62. Barth JH, Balen AH, Jennings A. Appropriate design of biochemistry request cards can promote the use of protocols and reduce unnecessary investigations. Ann Clin Biochem 2001;38:714-16. (Pubitemid 33702281)
63. Bailey J, Jennings A, Parapia L. Change of pathology request forms can reduce unwanted requests and tests. J Clin Pathol 2005;58:853-5. (Pubitemid 41113393)
64. van Wijk MA, van der Lei J, Mosseveld M, et al. Assessment of decision support for blood test ordering in primary care. A randomized trial. Ann Intern Med. 2001;134:274-81.
65. Smellie WSA. Time to harmonise common laboratory test profiles. Br Med J 2012;344:e1169.
66. Winkelman JW. Less utilization of the clinical laboratory produces disproportionately small true cost reductions. Hum Pathol 1984;15:499-501.
67. Kim JY, Dzik WH, Dighe AS, et al. Utilization management in a large urban academic medical center: a 10-yearexperience. Am J Clin Pathol 2011;135:108-18.
68. Broughton PM. The cost of unnecessary tests by day or night. Br Med J (Clin Res Ed) 1987;294:1503-4. (Pubitemid 17108381)
69. Cole GW. Maximising the efficiency of an admission test profile in a 680-bed hospital. Clin Chem 1980;26:46-50. (Pubitemid 10175854)
70. Kilpatrick ES. Can the addition of interpretative comments to laboratory reports influence outcome? An example involving patients taking thyroxine. Ann Clin Biochem 2004;41:227-9. (Pubitemid 38623149)
71. Kilpatrick ES, Freedman DB; National Clinical Biochemistry Audit Group. A national survey of interpretative reporting in the UK. Ann Clin Biochem 2011;48:317-20.
72. Vasikaran S. Interpretative commenting. Clin Biochem Rev 2008;29(Suppl 1): S99-103.
73. Marshall WJ, Challand GS. Provision of interpretative comments on biochemical report forms. Ann Clin Biochem 2000;37:758- 63.
74. Oxman AD, Thomson MA, Davis DA, et al. No magic bullets: A systematic review of 102 trials of interventions to improve professional practice. Can Med Assoc J 1995;153:1423-31.
75. Cummings KM, Frisof KB, Long MJ, et al. The effects of price information on physicians' test-ordering behavior. Ordering of diagnostic tests. Med Care 1982;20:293-301. (Pubitemid 12077086)
76. Hoey J, Eisenberg JM, Spitzer WO, et al. Physician Sensitivity to the price of diagnostic tests: A U.S.-Canadian analysis. Med Care 1982;20:302-7. (Pubitemid 12077087)
77. Smellie WSA, Galloway MJ, Chinn D. Benchmarking general practice use of pathology services - A model for monitoring change. J Clin Pathol 2000;53:476-80. (Pubitemid 30396472)
78. Eisenberg JM, Williams SV. Cost containment and changing physicians' practice behavior. Can the fox learn to guard the chicken coop? JAMA 1981;246:2195-201. (Pubitemid 11030567)
79. National Institute for Health and Clinical Excellence. Quality and Outcomes Framework. http://nice.org.uk/aboutnice/qof/indicators.jsp (accessed Aug 2012).
80. Magee GM, Hunter SJ, Cardwell CR, et al. Identifying additional patients with diabetic nephropathy using the UK primary care initiative. Diabet Med 2010;27:1372-8.
81. Smith AD, Shenkin A, Dryburgh FJ, et al. Emergency biochemistry services-are they abused? Ann Clin Biochem 1982;19:325-8. (Pubitemid 13251716)
82. Morgan DB, Gunn IR, Faye S, et al. A comparison of alternative arrangements for an out-of-hours chemical pathology service. Lancet 1985;1:859-61. (Pubitemid 15115126)
83. Prior M, Guerin M, Grimmer-Somers K. The effectiveness of clinical guideline implementation strategies-a synthesis of systematic review findings. J Eval Clin Pract 2008;14:888-97.
84. Sandler G. Costs of unnecessary tests. Br Med J 1979;2:21-4. (Pubitemid 9217468)
85. Hindmarsh JT, Lyon AW. Strategies to promote rational clinical chemistry test utilization. Clin Biochem 1996;29:291- 9.
86. Pathology Harmony. http://www.pathologyharmony.co.uk/ (accessed Aug 2012).
87. Cruickshank A, Auld P, Beetham R, et al. Revised national guidelines for analysis of cerebrospinal fluid for bilirubin in suspected subarachnoid haemorrhage. Ann Clin Biochem 2008;45:238-44. (Pubitemid 351724558)
88. Bairstow PJ, Mendelson R, Dhillon R, et al. Diagnostic imaging pathways: development, dissemination, implementation, and evaluation. Int J Qual Health Care 2006;18:51-7. (Pubitemid 43174766)
89. BetterTesting. http://www.bettertesting.org.uk/ (accessed May 2012).
90. Zackrisson B, Ulleryd P, Aus G, et al. Evolution of free, complexed, and total serum prostate-specific antigen and their ratios during 1 year of follow-up of men with febrile urinary tract infection. Urology 2003;62:278-81. (Pubitemid 36952077)
91. Lab Tests Online. http://www.labtestsonline.org.uk/ (accessed Aug 2012).
92. Lundberg GD. The need for an outcomes research agenda for clinical laboratory testing. JAMA 1998;280:565-6. (Pubitemid 28377680)
93. White AJ, Barraclough B. Benefits and problems of routine laboratory investigations in adult psychiatric admissions. Br J Psychiatry 1989;155:65-72. (Pubitemid 19188750)
94. Callen J, Georgiou A, Li J, et al. The safety implications of missed test results for hospitalised patients: a systematic review. BMJ Qual Saf 2011;20:194-9.
95. Sandler G. Do emergency tests help in the management of acute medical admissions? Br Med J (Clin Res Ed) 1984;289:973-7. (Pubitemid 14011164)
96. Fu C, Ji L, Wang W, et al. Frequency of HbA1c monitoring was inversely associated with glycemic control of patients with type 2 diabetes mellitus. J Endocrinol Invest 2012;35:269-73.
97. Turchin A, Goldberg SI, Breydo E, et al. Copy/paste documentation of lifestyle counselling and glycaemic control in patients with diabetes: true to form? Arch Intern Med 2011;171:1393-4.
98. Lundberg GD. Changing physician behavior in ordering diagnostic tests. JAMA 1998;280:2036. (Pubitemid 28562685)
99. Royal College of Pathologists. How to assess the quality of a pathology service. Oct 2011. http://www.rcpath.org/Resources/RCPath/Migrated%20Resources/ Documents/R/rcpathqualityevaluation3.pdf (accessed Aug 2012).
100. Barth JH. Selecting clinical quality indicators for laboratory medicine. Ann Clin Biochem 2012;49:257-61.